These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Graves' orbitopathy and restrictive myopathy. Biedner B; Marcus M; Yassur Y Thyroidology; 1991 May; 3(2):79-83. PubMed ID: 1726905 [TBL] [Abstract][Full Text] [Related]
63. Management of Graves' ophthalmopathy with optic nerve involvement. Feldon SE Mayo Clin Proc; 1993 Jun; 68(6):616-7. PubMed ID: 8497139 [No Abstract] [Full Text] [Related]
64. Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy. Marcocci C; Marinò M; Rocchi R; Menconi F; Morabito E; Pinchera A J Endocrinol Invest; 2004 Mar; 27(3):272-80. PubMed ID: 15165004 [TBL] [Abstract][Full Text] [Related]
65. Circulating monocyte migration inhibitory factor in serum of Graves' ophthalmopathy patients: a parameter for disease activity? van der Gaag R; Broersma L; Mourits MP; Koornneef L; Wiersinga WM; Prummel MP; Berghout A Clin Exp Immunol; 1989 Feb; 75(2):275-9. PubMed ID: 2649288 [TBL] [Abstract][Full Text] [Related]
66. Letter: Orbital radiotherapy for the ophthalmopathy of Graves's disease. Donaldson SS; Bagshaw MA; Kriss JP N Engl J Med; 1974 Apr; 290(14):805. PubMed ID: 4406001 [No Abstract] [Full Text] [Related]
67. Radiotherapy in benign orbital disease. II: Ophthalmic Graves' disease and orbital histiocytosis X. Harnett AN; Doughty D; Hirst A; Plowman PN Br J Ophthalmol; 1988 Apr; 72(4):289-92. PubMed ID: 3259894 [TBL] [Abstract][Full Text] [Related]
68. Surgical management of eye changes in Graves disease, with special emphasis on lid retraction. Boniuk M Trans New Orleans Acad Ophthalmol; 1982; 30():41-51. PubMed ID: 6896939 [No Abstract] [Full Text] [Related]
69. Perspective--Part I: the Mayo Orbital Radiotherapy for Graves Ophthalmopathy (ORGO) study: lessons learned. Bartley GB; Gorman CA Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):170-2. PubMed ID: 12021644 [No Abstract] [Full Text] [Related]